Why Vitalik Buterin sees quantum computing as a real threat to Ethereum’s cryptography, what experts expect and how the ...
Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.
We have some exciting news: Nominations are now open for MIT Technology Review’s 2026 Innovators Under 35 competition. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results